Literature DB >> 32364867

State Policies That Treat Prenatal Substance Use As Child Abuse Or Neglect Fail To Achieve Their Intended Goals.

Danielle N Atkins1, Christine Piette Durrance2.   

Abstract

The US is experiencing a complex substance abuse crisis. Not only has opioid overdose mortality increased sharply, by 400 percent from 1999 to 2017, but opioid use during pregnancy contributed to a 300 percent increase in neonatal abstinence syndrome (NAS)-a postnatal drug withdrawal syndrome in infants that is identified at birth-from 1999 to 2013. States have taken myriad policy approaches to combat the opioid crisis and its consequences, and some states have adopted punitive policies toward prenatal substance use. Using data for the period 2000-14 from the State Inpatient Databases of the Healthcare Cost and Utilization Project, this study examined the effect of state-level policies that treat prenatal substance use as child abuse or neglect on the incidence of NAS, maternal narcotic exposure, and substance use treatment admissions for pregnant women. We employed a difference-in-differences approach to estimate the effect of these policies. We did not find evidence that punitive prenatal substance use policies reduced NAS or maternal narcotic exposure at birth; however, we did find evidence that these policies may deter women from seeking substance use treatment during pregnancy. Policy makers might reconsider the efficacy of punitive policies and investigate increasing access to and reducing the cost of treatment for pregnant and parenting women.

Entities:  

Keywords:  Abstinence; Child abuse; Drug use; Health policy; Maternal health; Medicaid; Neonatal abstinence syndrome; Prenatal substance use; Punitive policy; Women's health; access to care; substance abuse

Mesh:

Year:  2020        PMID: 32364867     DOI: 10.1377/hlthaff.2019.00785

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  8 in total

1.  Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy.

Authors:  Sugy Choi; Michael D Stein; Julia Raifman; David Rosenbloom; Jack A Clark
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

2.  Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy.

Authors:  Anna E Austin; Rebecca B Naumann; Elizabeth Simmons
Journal:  JAMA Pediatr       Date:  2022-09-19       Impact factor: 26.796

3.  A response to 'Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments'.

Authors:  Julia Reddy; Davida Schiff
Journal:  Addiction       Date:  2021-09-08       Impact factor: 6.526

4.  Prenatal substance use policies and newborn health.

Authors:  Angélica Meinhofer; Allison Witman; Johanna Catherine Maclean; Yuhua Bao
Journal:  Health Econ       Date:  2022-04-20       Impact factor: 2.395

5.  Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.

Authors:  Nadia Tabatabaeepour; Jake R Morgan; Ali Jalali; Shashi N Kapadia; Angélica Meinhofer
Journal:  J Subst Abuse Treat       Date:  2022-05-10

6.  Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments.

Authors:  Laura J Faherty; Sara Heins; Ashley M Kranz; Stephen W Patrick; Bradley D Stein
Journal:  Addiction       Date:  2021-07-07       Impact factor: 6.526

7.  Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: "We Don't Do That Here".

Authors:  Julia C Phillippi; Rebecca Schulte; Kemberlee Bonnet; David D Schlundt; William O Cooper; Peter R Martin; Katy B Kozhimannil; Stephen W Patrick
Journal:  Womens Health Issues       Date:  2021-06-02

8.  Motherhood, pregnancy and gateways to intervene in substance use disorder.

Authors:  Sugy Choi; Michael D Stein; Julia Raifman; David Rosenbloom; Jack A Clark
Journal:  Health Soc Care Community       Date:  2021-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.